THERACLONE SCIENCES

Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for la... rge-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.

#SimilarOrganizations #People #Financial #Website #More

THERACLONE SCIENCES

Social Links:

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2004-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.theraclone-sciences.com

Total Employee:

11+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

63.19 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail

Similar Organizations

abacus-bioscience-logo

Abacus Bioscience

Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.

amakem-logo

Amakem

Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

connect-biopharmaceuticals-logo

Connect Biopharmaceuticals

Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

emphasys-medical-logo

Emphasys Medical

Emphasys Medical develops therapeutic devices for the treatment of patients with emphysema and other breathing disorders.

epicyte-pharmaceuticals-logo

Epicyte Pharmaceuticals

Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.

nereus-pharmaceuticals-logo

Nereus Pharmaceuticals

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

park-therapeutics-logo

Park Therapeutics

Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready.

sound-alignment-logo

Sound Alignment

Sound Alignment is a web portal that enables vibration based therapeutics studies to be a remotely function via mobile devices.

validus-cellular-therapeutics-logo

Validus Cellular Therapeutics

Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.

wise-anderson-protocol-logo

Wise Anderson Protocol

The Wise-Anderson Protocol was developed at Stanford University in the Department of Urology by David Wise, Ph.D. and Rodney Anderson M.D.

Current Advisors List

wende-hutton_image

Wende Hutton Board Member @ Theraclone Sciences
Board_member

wendye-robbins_image

Wendye Robbins Board of Directors @ Theraclone Sciences
Board_member

not_available_image

Christopher K. Mirabelli Board of Directors @ Theraclone Sciences
Board_member

steven-gillis_image

Steven Gillis Member of the Board of Directors @ Theraclone Sciences
Board_member

Current Employees Featured

steven-gillis_image

Steven Gillis
Steven Gillis Acting President @ Theraclone Sciences
Acting President

Founder

johnny-stine_image

Johnny Stine

Investors List

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series B - Theraclone Sciences

midcap-financial_image

MidCap Financial

MidCap Financial investment in Debt Financing - Theraclone Sciences

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Theraclone Sciences

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Theraclone Sciences

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Theraclone Sciences

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - Theraclone Sciences

zenyaku-kogyo_image

Zenyaku Kogyo

Zenyaku Kogyo investment in Series B - Theraclone Sciences

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series B - Theraclone Sciences

alexandria-real-estate-equities_image

Alexandria Real Estate Equities

Alexandria Real Estate Equities investment in Series B - Theraclone Sciences

healthcare-ventures_image

HealthCare Ventures

HealthCare Ventures investment in Series B - Theraclone Sciences

Official Site Inspections

http://www.theraclone-sciences.com

Host Informations
Whois Informations

Loading ...

More informations about "Theraclone Sciences" on Search Engine